研究论文
Paclitaxel plus platinum-based chemotherapy versus conventional platinum-based chemotherapy in women with relapsed ovarian cancer: the ICON4/AGO-OVAR-2.2 trial
Mahesh Parmar, Jonathan Andrew Ledermann, Nicoletta Colombo, Andreas du Bois, Delaloye Jf, Gunnar Balle Kristensen, S Wheeler, Ann Marie Swart 等 14 位
阅读操作
确认中在文库中上传 PDF 后可生成中文音频讲解。
摘要与影响
摘要 · 节选
暂未获取摘要。可打开原文或 PDF，后续可基于全文生成更完整的速读。
逐年被引趋势
46230
17
18
19
20
4621
22
23
24
25
26
关键指标
1,175
被引次数 · OpenAlex
50.29
领域内被引倍数
同类平均 = 1
同类平均 = 1
前 0.1%
引用位次
同领域 · 同年份 · 同类型
同领域 · 同年份 · 同类型
18
参考文献
Google Scholar 与 OpenAlex 的被引统计范围不同，数值存在差异属正常。
AI 辅助阅读
依据：文献信息
论文问答
当前基于文献信息回答
可就本文提问；依据不足时会说明。
学术脉络
学科主题
生物医学Ovarian cancer diagnosis and treatment
Cancer Treatment and Pharmacology · PARP inhibition in cancer therapy
参考文献 18
Chemotherapy in advanced ovarian cancer: four systematic meta-analyses of individual patient data from 37 randomized trials
被引 234Advanced Ovarian Cancer Trialists' Group, Kristian Aabo, Malcolm Adams · British Journal of Cancer · 1998
Phase III Randomized Study of Cisplatin Versus Paclitaxel Versus Cisplatin and Paclitaxel in Patients With Suboptimal Stage III or IV Ovarian Cancer: A Gynecologic Oncology Group Study
被引 594Franco M. Muggia, Patricia S. Braly, Mark F. Brady · Journal of Clinical Oncology · 2000
Paclitaxel for platinum-refractory ovarian cancer: results from the first 1,000 patients registered to National Cancer Institute Treatment Referral Center 9103.
被引 267Edward Lloyd Trimble, Jascha Adams, Donald A. Vena · Journal of Clinical Oncology · 1993
此处列出前 3 条
引用本文 1,175
Cancer of the Ovary
被引 2,123SA Cannistra · New England Journal of Medicine · 2004
Epithelial ovarian cancer
被引 1,962Stéphanie Lheureux, Charlie Gourley, Ignace B. Vergote · The Lancet · 2019
Olaparib Maintenance Therapy in Platinum-Sensitive Relapsed Ovarian Cancer
被引 1,891Jonathan Andrew Ledermann, Philipp Harter, Charlie Gourley · New England Journal of Medicine · 2012
按被引量排序，此处列出前 3 条